Jönsson-Berling B M, Ohlsson K
Department of Surgical Pathophysiology, Malmö General Hospital, University of Lund, Sweden.
Scand J Clin Lab Invest. 1991 Oct;51(6):549-57. doi: 10.3109/00365519109104564.
Elimination of human urinary trypsin inhibitor (UTI) after intravenous injection of 125I-labelled UTI was followed by serial plasma and urine samples in three male volunteers. The plasma half-life of 125IUTI during 0-3 h after injection was 33 min and during the following 4 hours the half-life was 2 hours. Free, biologically active inhibitor was found in the urine during the first four hours after injection. Most of the radioactivity in the urine, however, corresponded to free 125I probably released during the degradation of UTI in the kidney. The distribution of UTI was studied after injection of 125IUTI in rats by measurement of radioactivity in excised organs. Fifteen min after the injection 44% of the radioactivity was found in the kidneys and 9% in the liver, implying that the kidneys are the primary site of UTI metabolism.
在三名男性志愿者静脉注射125I标记的人尿胰蛋白酶抑制剂(UTI)后,通过连续采集血浆和尿液样本追踪UTI的消除情况。注射后0至3小时内,125I-UTI的血浆半衰期为33分钟,在接下来的4小时内半衰期为2小时。注射后的前四个小时内,尿液中发现了游离的、具有生物活性的抑制剂。然而,尿液中的大部分放射性对应于可能在肾脏中UTI降解过程中释放的游离125I。通过测量切除器官中的放射性,研究了在大鼠中注射125I-UTI后UTI的分布情况。注射后15分钟,44%的放射性出现在肾脏中,9%出现在肝脏中,这意味着肾脏是UTI代谢的主要部位。